For improving the precision medicine probe competitiveness and capableness of Seoul National University Bundang Hospital
Seoul National University (SNU) Bundang Hospital Biomedical Research Institute has concluded a Memorandum of Understanding (MoU) to standardise clinico genomic probe utilizing US-based Cipherome, Inc.’s precision medicine probe level astatine Precision Medicine Centre.
Precision Medicine Centre, an integral portion of the Future Innovation Research Department of Seoul National University Bundang Hospital, South Korea, successful supporting aesculapian staffs with genomics acquisition programmes and probe enactment programmes, is presently establishing large-scale cohorts based connected the hospital’s quality biobank.
Because of the precocious request for tools to organise, vet, and execute genomic and objective information probe and the deficiency of accessible tools for objective researchers, Cipherome has commercialised its information investigation improvement system, the Compass Platform, to empower objective researchers to transportation retired analyzable information subject tasks, from statistical investigation to instrumentality learning training, connected genomic and objective information efficiently and rapidly. A superior extremity is to shorten the clip to results of population-scale extrapolations utilizing UK BioBank data.
Ji-Soo Kim, the president of Seoul National University Bundang Hospital Biomedical Research Institute, stated, “Through this MoU with Cipherome, we volition actively enactment the precision medicine R&D based connected objective and genomic large data. We volition proceed to fortify our probe capableness to instrumentality the pb of the precision medicine successful the planetary market.”
English (US)